H2020 funding for respiratory research: scaling up for the prevention and treatment of lung diseases-Reference-Cited by-同舟云学术

H2020 funding for respiratory research: scaling up for the prevention and treatment of lung diseases

Published:2019-09 Issue:3 Volume:54 Page:1901417
ISSN:0903-1936
Container-title:European Respiratory Journal
language:en
Short-container-title:Eur Respir J

Author:

Vardavas Constantine I.,Kyriakos Christina N.^ORCID,Fernández Esteve^ORCID,Bamidis Panagiotis,Siddiqi Kamran^ORCID,Chavannes Niels H.,van der Kleij R.M.J.J.,Parker Gary,Radu-Loghin Cornel,Ward Brian,Berkouk Karim

Funder

Horizon 2020 Framework Programme

Publisher

European Respiratory Society (ERS)

Subject

Pulmonary and Respiratory Medicine

Reference29 articles.

1. Respiratory health and disease in Europe: the new European Lung White Book

2. Global alliance against chronic respiratory diseases;Bousquet;Allergy Eur J Allergy Clin Immunol,2007

3. The European Respiratory Society's 10 Principles for Lung Health

4. Chronic respiratory diseases and lung cancer research: a perspective from the European Union

5. European Commission. Global Alliance for Chronic Diseases. Prevention and treatment of lung diseases HCO-06-2015. https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/hco-06-2015 Date last updated: 11 December 2013.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does combined training of biofeedback and neurofeedback affect smoking status, behavior, and longitudinal brain plasticity?;Frontiers in Behavioral Neuroscience;2023-01-27

2. Prioritising primary care respiratory research needs: results from the 2020 International Primary Care Respiratory Group (IPCRG) global e-Delphi exercise;npj Primary Care Respiratory Medicine;2022-01-28

3. Effectiveness of a smoking cessation decision-making electronic tool (Pare de Fumar Conosco): A randomized clinical trial;Health Informatics Journal;2022-01

4. Research priorities to address the global burden of chronic obstructive pulmonary disease (COPD) in the next decade;Journal of Global Health;2021-10-09

5. Advanced human-relevant in vitro pulmonary platforms for respiratory therapeutics;Advanced Drug Delivery Reviews;2021-09